Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 18 04:00PM ET
83.66
Dollar change
+0.09
Percentage change
0.11
%
IndexS&P 500 P/E26.54 EPS (ttm)3.15 Insider Own0.07% Shs Outstand1.33B Perf Week-2.15%
Market Cap111.09B Forward P/E15.35 EPS next Y5.45 Insider Trans-3.70% Shs Float1.33B Perf Month-1.25%
Income4.20B PEG7.63 EPS next Q1.45 Inst Own85.29% Short Float0.64% Perf Quarter0.28%
Sales32.32B P/S3.44 EPS this Y-1.78% Inst Trans1.45% Short Ratio1.37 Perf Half Y2.31%
Book/sh38.95 P/B2.15 EPS next Y4.90% ROA4.54% Short Interest8.45M Perf Year5.54%
Cash/sh6.27 P/C13.35 EPS next 5Y3.48% ROE8.14% 52W Range68.84 - 92.02 Perf YTD1.55%
Dividend Est.2.64 (3.15%) P/FCF22.53 EPS past 5Y4.43% ROI5.53% 52W High-9.08% Beta0.77
Dividend TTM2.75 (3.29%) Quick Ratio1.71 Sales past 5Y0.91% Gross Margin60.32% 52W Low21.53% ATR (14)1.37
Dividend Ex-DateMar 21, 2024 Current Ratio2.30 EPS Y/Y TTM3.59% Oper. Margin18.50% RSI (14)42.50 Volatility1.28% 1.73%
Employees95000 Debt/Eq0.49 Sales Y/Y TTM5.03% Profit Margin13.00% Recom2.38 Target Price93.53
Option/ShortYes / Yes LT Debt/Eq0.47 EPS Q/Q8.21% Payout96.47% Rel Volume0.77 Prev Close83.57
Sales Surprise1.71% EPS Surprise3.04% Sales Q/Q4.68% EarningsFeb 20 BMO Avg Volume6.17M Price83.66
SMA20-1.26% SMA50-2.28% SMA2001.95% Trades Volume4,783,947 Change0.11%
Date Action Analyst Rating Change Price Target Change
Jul-19-23Initiated Robert W. Baird Neutral $90
Jun-30-23Initiated CL King Buy $106
May-30-23Upgrade Morgan Stanley Equal-Weight → Overweight $104
Apr-24-23Upgrade Wells Fargo Equal Weight → Overweight $77 → $100
Mar-29-23Downgrade UBS Buy → Sell $127 → $79
Jan-09-23Downgrade RBC Capital Mkts Outperform → Sector Perform $102 → $89
Nov-23-22Downgrade Oppenheimer Outperform → Perform $106 → $85
Nov-23-22Downgrade Citigroup Buy → Neutral $108 → $85
Nov-16-22Downgrade Deutsche Bank Buy → Hold $85
Oct-18-22Initiated Barclays Equal Weight $90
Mar-18-24 03:30AM
Mar-17-24 02:36PM
04:45AM
Mar-15-24 06:00AM
Mar-13-24 08:00AM
08:03AM Loading…
Mar-12-24 08:03AM
06:00AM
Mar-11-24 09:17AM
Mar-09-24 05:40AM
Mar-08-24 09:15AM
06:52AM
Mar-07-24 04:20PM
Mar-06-24 08:37AM
06:34AM
Mar-05-24 04:30PM
06:37AM Loading…
06:37AM
04:44AM
Mar-04-24 03:50PM
Mar-01-24 12:22AM
Feb-29-24 09:00AM
07:12AM
Feb-26-24 08:00AM
07:05AM
Feb-25-24 02:37PM
Feb-23-24 11:24PM
Feb-22-24 09:15AM
01:08AM
Feb-21-24 09:53AM
09:52AM
09:15AM
09:04AM Loading…
09:04AM
Feb-20-24 09:22PM
04:02PM
02:19PM
02:06PM
01:55PM
12:50PM
12:30PM
12:27PM
10:45AM
10:01AM
09:59AM
09:30AM
08:59AM
08:31AM
08:08AM
07:55AM
07:30AM
07:12AM
07:05AM
06:56AM
06:54AM
06:52AM
06:45AM
Feb-18-24 01:26PM
Feb-16-24 07:15AM
06:11AM
Feb-14-24 05:45PM
09:15AM
Feb-13-24 02:41PM
02:09PM
Feb-12-24 11:24AM
Feb-09-24 07:32AM
Feb-08-24 05:45PM
Feb-07-24 12:45PM
Feb-06-24 11:00AM
10:41AM
09:11AM
07:15AM
06:15AM
Feb-05-24 05:50PM
09:50AM
Feb-03-24 10:00AM
Jan-31-24 12:44PM
Jan-30-24 05:50PM
06:15AM
Jan-28-24 11:42AM
Jan-27-24 05:05AM
Jan-25-24 05:44AM
Jan-24-24 08:40PM
05:50PM
01:58PM
Jan-23-24 05:55PM
11:45AM
06:45AM
06:00AM
Jan-22-24 12:45PM
01:43AM
Jan-21-24 03:45PM
06:17AM
Jan-18-24 05:50PM
Jan-16-24 11:15AM
Jan-13-24 06:05AM
Jan-11-24 08:00PM
05:50PM
07:06AM
05:39AM
Jan-10-24 07:45AM
07:07AM
Jan-09-24 06:42AM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salmon SeanEVP & President CardiovascularFeb 21 '24Option Exercise69.0730,6952,120,12178,984Feb 23 05:18 PM
Salmon SeanEVP & President CardiovascularFeb 21 '24Sale85.1330,6952,613,05548,289Feb 23 05:18 PM
Wall Brett A.EVP & Pres NeuroscienceDec 19 '23Sale82.174,997410,60328,910Dec 20 11:41 AM
Smith Gregory LEVP Global Ops & Supply ChainAug 23 '23Sale83.8410,000838,40046,723Aug 25 03:21 PM
Wall Brett A.EVP & Pres NeuroscienceAug 14 '23Sale83.381,00083,38033,573Aug 16 05:16 PM
Marinaro MichaelEVP & President, Surgical OUAug 04 '23Sale84.111,352113,71728,930Aug 07 08:47 PM
Wall Brett A.EVP & Pres NeuroscienceJul 14 '23Sale87.972,000175,94023,948Jul 18 04:16 PM
TEN HOEDT ROBEVP and Pres. Global RegionsJul 10 '23Option Exercise55.325,514305,03447,508Jul 12 03:48 PM
TEN HOEDT ROBEVP and Pres. Global RegionsJul 10 '23Sale86.585,514477,42043,802Jul 12 03:48 PM